Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea
Phillips 2013 trial design and results
Design
Randomised crossover trial
Treatment
Mandibular advancement device
Control
CPAP
Population
126 patients with moderate to severe obstructive sleep apnoea
Follow-up
1 month per treatment period
Primary endpoint
Health outcomes including blood pressure, sleepiness, quality of life and neurobehavioural function
Result
CPAP reduced the apnoea-hypopnoea index more than the oral appliance (4.5±6.6 versus 11.1±12.1 per hour) but was used for fewer hours. Neither device lowered 24-hour mean arterial pressure, the primary outcome, and health outcomes were similar after one month of each. 126 patients with moderate-to-severe apnoea (mean AHI 25.6) were randomised and 108 completed both treatments.
Important health outcomes were similar after 1 month of optimal MAD and CPAP treatment in patients with moderate-severe OSA. The results may be explained by greater efficacy of CPAP being offset by inferior compliance relative to MAD.
The trial authors, in the published abstract
How it has aged
The single most useful idea in sleep apnoea therapeutics — effectiveness is efficacy multiplied by adherence. It explains why an inferior device ties with a superior one, and why the adherence figures in SAVE matter so much to that trial's interpretation.
Publications
Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial
Phillips CL, Grunstein RR, Darendeliler MA, et al. Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med 2013 Apr 15;187(8):879-87.
Similar health outcomes to CPAP after one month
Lower efficacy per hour offset by better adherence